Working… Menu
Trial record 4 of 6 for:    atalante

ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab (ATALANTE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02891824
Recruitment Status : Active, not recruiting
First Posted : September 8, 2016
Last Update Posted : January 22, 2021
Hoffmann-La Roche
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : September 2024